MXPA05011249A - Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol. - Google Patents
Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol.Info
- Publication number
- MXPA05011249A MXPA05011249A MXPA05011249A MXPA05011249A MXPA05011249A MX PA05011249 A MXPA05011249 A MX PA05011249A MX PA05011249 A MXPA05011249 A MX PA05011249A MX PA05011249 A MXPA05011249 A MX PA05011249A MX PA05011249 A MXPA05011249 A MX PA05011249A
- Authority
- MX
- Mexico
- Prior art keywords
- desoxypeganine
- mecamylamine
- treatment
- combination
- alcohol abuse
- Prior art date
Links
- 208000007848 Alcoholism Diseases 0.000 title abstract 3
- WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 title abstract 2
- 206010001584 alcohol abuse Diseases 0.000 title abstract 2
- 208000025746 alcohol use disease Diseases 0.000 title abstract 2
- IMYZQPCYWPFTAG-IQJOONFLSA-N mecamylamine Chemical compound C1C[C@@H]2C(C)(C)[C@@](NC)(C)[C@H]1C2 IMYZQPCYWPFTAG-IQJOONFLSA-N 0.000 title abstract 2
- 229960002525 mecamylamine Drugs 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
Abstract
La invencion se refiere a la combinacion de principios activos, que esta constituida por desoxipeganina o uno de sus derivados aceptables desde el punto de vista farmaceutico y mecamilamina o uno de sus derivados aceptables desde el punto de vista farmaceutico que sirve para la fabricacion de un medicamento para el tratamiento del abuso de alcohol y/o la dependencia del alcohol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10318714A DE10318714B4 (de) | 2003-04-25 | 2003-04-25 | Wirkstoff-Kombinationen und Therapien zur Bekämpfung des Alkoholmissbrauches |
| PCT/EP2004/004033 WO2004096200A1 (de) | 2003-04-25 | 2004-04-16 | Kombination aus desoxypeganin und mecamylamin zur behandlung des alkoholmissbrauches |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05011249A true MXPA05011249A (es) | 2005-12-14 |
Family
ID=33304936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05011249A MXPA05011249A (es) | 2003-04-25 | 2004-04-16 | Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20060199866A1 (es) |
| EP (1) | EP1617831A1 (es) |
| JP (1) | JP2006524647A (es) |
| KR (1) | KR20060006946A (es) |
| CN (1) | CN1771029A (es) |
| AR (1) | AR044067A1 (es) |
| AU (1) | AU2004233564A1 (es) |
| BR (1) | BRPI0410507A (es) |
| CA (1) | CA2523331A1 (es) |
| CL (1) | CL2004000881A1 (es) |
| DE (1) | DE10318714B4 (es) |
| EA (1) | EA200501514A1 (es) |
| MX (1) | MXPA05011249A (es) |
| MY (1) | MY136408A (es) |
| NO (1) | NO20054243L (es) |
| TW (1) | TW200427452A (es) |
| WO (1) | WO2004096200A1 (es) |
| ZA (1) | ZA200507213B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090005367A1 (en) * | 2006-10-10 | 2009-01-01 | Murray James Propes | Composition and method for treating alcoholism and other substance addictions |
| CN108498493A (zh) * | 2017-02-27 | 2018-09-07 | 中国人民解放军第二军医大学 | 美加明防治晕动症或眩晕症的医药用途 |
| KR102728780B1 (ko) * | 2021-11-30 | 2024-11-08 | 이화여자대학교 산학협력단 | 데옥시바시시논을 유효성분으로 포함하는 미백용 조성물 및 상기 데옥시바시시논 제조방법 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
| US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
| US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
| US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
| DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
| US5316759A (en) * | 1986-03-17 | 1994-05-31 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
| DE3843239C1 (es) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
| JP2001518520A (ja) * | 1997-10-03 | 2001-10-16 | キャリー メディカル コーポレイション | ニコチンレセプターアンタゴニストおよび抗抑うつ薬または抗不安薬を含有するニコチン嗜癖を治療する組成物 |
| CA2393437C (en) * | 1998-12-16 | 2009-12-15 | University Of South Florida | Exo-s-mecamylamine formulation and use in treatment |
| DE19906974C2 (de) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Verwendung von Desoxypeganin zur Behandlung des Alkoholismus |
| DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
-
2003
- 2003-04-25 DE DE10318714A patent/DE10318714B4/de not_active Expired - Fee Related
-
2004
- 2004-04-16 KR KR1020057020318A patent/KR20060006946A/ko not_active Withdrawn
- 2004-04-16 CN CNA2004800094893A patent/CN1771029A/zh active Pending
- 2004-04-16 MX MXPA05011249A patent/MXPA05011249A/es not_active Application Discontinuation
- 2004-04-16 JP JP2006505158A patent/JP2006524647A/ja active Pending
- 2004-04-16 AU AU2004233564A patent/AU2004233564A1/en not_active Abandoned
- 2004-04-16 BR BRPI0410507-9A patent/BRPI0410507A/pt not_active Application Discontinuation
- 2004-04-16 WO PCT/EP2004/004033 patent/WO2004096200A1/de not_active Ceased
- 2004-04-16 EA EA200501514A patent/EA200501514A1/ru unknown
- 2004-04-16 CA CA002523331A patent/CA2523331A1/en not_active Abandoned
- 2004-04-16 US US10/554,350 patent/US20060199866A1/en not_active Abandoned
- 2004-04-16 EP EP04727830A patent/EP1617831A1/de not_active Withdrawn
- 2004-04-22 MY MYPI20041476A patent/MY136408A/en unknown
- 2004-04-23 AR ARP040101378A patent/AR044067A1/es unknown
- 2004-04-23 TW TW093111538A patent/TW200427452A/zh unknown
- 2004-04-26 CL CL200400881A patent/CL2004000881A1/es unknown
-
2005
- 2005-09-08 ZA ZA200507213A patent/ZA200507213B/en unknown
- 2005-09-13 NO NO20054243A patent/NO20054243L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0410507A (pt) | 2006-06-20 |
| MY136408A (en) | 2008-09-30 |
| CN1771029A (zh) | 2006-05-10 |
| US20060199866A1 (en) | 2006-09-07 |
| AU2004233564A1 (en) | 2004-11-11 |
| WO2004096200A1 (de) | 2004-11-11 |
| DE10318714A1 (de) | 2004-11-18 |
| CL2004000881A1 (es) | 2005-01-21 |
| TW200427452A (en) | 2004-12-16 |
| ZA200507213B (en) | 2006-05-31 |
| DE10318714B4 (de) | 2006-03-23 |
| CA2523331A1 (en) | 2004-11-11 |
| EA200501514A1 (ru) | 2006-04-28 |
| AR044067A1 (es) | 2005-08-24 |
| NO20054243L (no) | 2005-09-13 |
| KR20060006946A (ko) | 2006-01-20 |
| EP1617831A1 (de) | 2006-01-25 |
| JP2006524647A (ja) | 2006-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0703786T3 (da) | Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS | |
| IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
| GB0031088D0 (en) | Medicaments | |
| GB0118238D0 (en) | Medicaments | |
| GB0112836D0 (en) | Medicaments | |
| NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
| PL366430A1 (en) | Sustained release formulations of oxymorphone | |
| AU2003220317A1 (en) | Methods and drug delivery systems for the treatment of orofacial diseases | |
| AU2002236647A1 (en) | Method and device for administering medication and/or placebo | |
| AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
| MXPA05008406A (es) | Compuestos de amida tri(ciclo)-sustituida. | |
| MXPA04005980A (es) | Un metodo y dispositivo para reducir dosificacion terapeutica. | |
| AUPR839001A0 (en) | Dosage form, device and methods of treatment | |
| EP1534295A4 (en) | FORMULATIONS AND METHODS OF ADMINISTRATION OF CEPHALOTAXINS, INCLUDING HOMOHARRINGTONIN | |
| WO2005039481A3 (en) | Oral drug delivery system | |
| AU6528400A (en) | Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms | |
| AU2002226427A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
| DE60102590T2 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| DE69941825D1 (de) | Arzneistoffhaltiger kaugummi, dessen herstellungsverfahren und so erhaltene tablette | |
| IL150289A0 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine | |
| GB0020504D0 (en) | Therapeutic method | |
| IL162768A0 (en) | Method of treatment of a patient requiring analgesia | |
| NZ528164A (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
| WO2002053149A3 (de) | Arzneimittel enthaltend ein polyamin als wirksubstanz | |
| MXPA05011249A (es) | Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |